Daiichi Sankyo’s pipeline technique: Turning into a pacesetter in oncology
Daiichi Sankyo has just lately set out on an bold strategic purpose. Having established itself as a pacesetter in antibody-drug conjugates (ADCs) ...
Tag: Daiichi
The world's leading source for AI research, emerging technology, and the people building the future. Independent, rigorous, and always ahead.